Quest Diagnostics Inc.

613 articles about Quest Diagnostics Inc.

• 

  Quest Launches Alzheimer’s Beta-Amyloid Blood Test for Consumers

  8/1/2023

  Amid a re-energized Alzheimer’s disease space, Quest Diagnostics offers what the company contends is the first direct-to-consumer blood-based biomarker test to assess disease risk.

• QUEST DIAGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS; PROVIDES GUIDANCE FOR FULL YEAR 2023

  2/2/2023

  Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the fourth quarter and full year ended December 31, 2022.

• Quest Diagnostics Increases Dividend 7.6% To $0.71 Per Quarter; Announces $1 Billion Increase in Share Repurchase Authorization

  2/2/2023

  Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today the Company's Board of Directors has authorized a 7.6% increase in its quarterly dividend from $0.66 to $0.71 per share.

• Quest Diagnostics Reports Third Quarter 2022 Financial Results; Raises Guidance for Full Year 2022

  10/20/2022

  Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the third quarter ended September 30, 2022.

• 

  Companies Proving They're Good for More than COVID-19 Diagnostics

  7/22/2021

  For the past year, Abbott Laboratories and Quest Diagnostics saw their revenue driven by COVID-19 diagnostics, but that seems to be changing as more and more vaccinated individuals are seeking medical advice for non-viral related issues.
• 

  Biopharma Update on the Novel Coronavirus: April 28

  4/28/2020

  Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 28, 2020.

• Quest Diagnostics To Release First Quarter 2020 Financial Results On April 22

  4/7/2020

  Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2020 results on Wednesday, April 22, 2020 , before the market opens.  It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that

• 

  Update: Nearly 12 Million Patients Fall Victim to Quest Diagnostics' Data Breach

  6/4/2019

  Information exposed in the hacking includes financial data, Social Security numbers and medical information, Quest said.

• Quest Diagnostics Now Participating in NCI-MATCH Precision Medicine Clinical Trial

  5/29/2019

  Quest Diagnostics announced it is participating as a designated laboratory in the NCI-Molecular Analysis for Therapy Choice precision medicine trial, the largest precision medicine trial of its kind.

• Quest Diagnostics To Speak At The UBS Global Healthcare Conference

  5/13/2019

  Quest Diagnostics Incorporated, the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the UBS Global Healthcare Conference in New York.

• Quest Diagnostics Reports First Quarter 2019 Financial Results

  4/23/2019

  First quarter reported diluted EPS of $1.20, down 5.4% from 2018; and adjusted diluted EPS of $1.40, down 7.9% from 2018

• Forbes Names Quest Diagnostics One of America's Best Large Employers

  4/22/2019

  Quest Diagnostics Incorporated, the world's leading provider of diagnostic information services, announced that it was selected by Forbes as one of America's Best Large Employers of 2019.

• Quest Diagnostics To Release First Quarter 2019 Financial Results On April 23

  4/4/2019

  Quest Diagnostics Incorporated, the world's leading provider of diagnostic information services, announced that it will report first quarter 2019 results on Tuesday, April 23, 2019, before the market opens.

• Quest Diagnostics Achieves Perfect Score On 2019 Human Rights Campaign Corporate Equality Index for Third Consecutive Year

  4/1/2019

  Quest Diagnostics Incorporated, the world's leading provider of diagnostic information services, received a perfect score of 100 from the Human Rights Campaign Foundation on the 2019 Corporate Equality Index, earning the distinction of being a "Best Place to Work for LGBTQ Equality."

• Quest Diagnostics To Speak At The Barclays Global Healthcare Conference - March 7, 2019

  3/7/2019

  Quest Diagnostics Incorporated, the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Barclays Global Healthcare Conference in Miami.

• Quest Diagnostics Prices $500 Million of Senior Notes - March 7, 2019

  3/7/2019

  Quest Diagnostics Incorporated, the world's leading provider of diagnostic information services, announced the pricing of a public offering of $500 million aggregate principal amount of its 4.200% senior notes due 2029 under the Quest Diagnostics' shelf registration statement.

• Quest Diagnostics Reports Fourth Quarter And Full Year 2018 Financial Results; Provides Guidance For Full Year 2019

  2/14/2019

  Fourth quarter diluted EPS of $0.92 on a reported basis, down 49.5% from 2017 which included a tax benefit recorded as a result of the Tax Cuts and Jobs Act (TCJA); and $1.36 on an adjusted basis excluding amortization, down 2.9% from 2017

• Quest Diagnostics To Release Fourth Quarter And Full Year 2018 Financial Results On February 14

  1/7/2019

  Quest Diagnostics Incorporated announced that it will report fourth quarter and full year 2018 results on Thursday, February 14, 2019, before the market opens

• Quest Diagnostics, a Pioneer in Consumer Health, Expands Offering with Launch of QuestDirect, a Service that Provides Consumers Access to Lab Testing without Visiting a Doctor's Office

  11/7/2018

  QuestDirect Builds on Quest's existing consumer offerings available through the new and improved MyQuest patient platform that lets people access their lab results, schedule appointments and pay bills

• Quest Diagnostics to Speak at the 2018 Morgan Stanley Global Healthcare Conference

  9/7/2018

  Quest Diagnostics Incorporated announced that it is scheduled to speak at the Morgan Stanley Global Healthcare Conference in New York City.